Drug Shortage Report for LOVENOX
Report ID | 135328 |
Drug Identification Number | 02378434 |
Brand name | LOVENOX |
Common or Proper name | Lovenox |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ENOXAPARIN SODIUM |
Strength(s) | 80MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 10 |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-03-19 |
Actual start date | |
Estimated end date | 2021-03-26 |
Actual end date | 2021-03-15 |
Shortage status | Avoided shortage |
Updated date | 2021-03-16 |
Company comments | Shortage avoided |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-03-09 | English | Compare |
v2 | 2021-03-09 | French | Compare |
v3 | 2021-03-16 | English | Compare |
v4 | 2021-03-16 | French | Compare |
Showing 1 to 4 of 4